Pharmaceutical Industry Information Portal

HomeNews

News

R-Pharm presented results of phase III global research program – CREDO

In the framework of the annual ACR Convergence 2021, R-Pharm Group presented successful results of olokizumab in two randomized clinical trials of phase III global research program — CREDO (Clinical RhEumatoid Arthritis Development...

Haikou city opens Hainan’s first pharmaceutical equipment service base

Haikou city, the administrative center of Hainan, announced the opening of the island's first modern pharmaceutical equipment maintenance facility,  TASS reports with a reference...

Expert RA assigns an expected ruA credit rating to Binnopharm Group’s planned bond issue

Binnopharm Group, a holding company that combines Sistema’s pharmaceutical assets, announces that the Expert RA rating agency has assigned an expected ruA credit rating...

Revenue of PROMOMED DM LLC for 9 months of 2021 increased by 194.74% and amounted to RUB 13.25 bln.

PROMOMED DM LLC publishes financial statements for 9 months of 2021 compiled in accordance with Russian Accounting Standards (RAS). According to the results of 9...

What veterinary medicines manufacturers ask about?

On September 22-24, the VI All Russia GMP Conference with international participation, organized by the Ministry of Industry and Trade of Russia together with...

Research Center of Mendeleev University and Ferring will develop innovative pharmaceuticals for Russia

The research center of the university will be engaged in the development of new drugs for Russia with improved characteristics of safety and bioavailability profiles, increased stability and ease of use. First of all, they will be innovative pharmaceuticals for women's health, reproductive medicine, neurology and immunology.
spot_img

Expert Articles

spot_img